Anees M Dauki (Anees Dauki)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Drug Administration

Acute Myeloid Leukemia

Regulatory T Cells

Tyrosine Kinase

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical and translational science

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Anthony W Tolcher, Joshua D Brody, Nishanthan Rajakumaraswamy, Michelle R Kuhne, Torsten Trowe, Anees M Dauki, Shantheri Pai, Ling Han, Kai-Wen Lin, Michael Petrarca, Shivaani Kummar
Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Anthony W Tolcher, Joshua D Brody, Nishanthan Rajakumaraswamy, Michelle R Kuhne, Torsten Trowe, Anees M Dauki, Shantheri Pai, Ling Han, Kai-Wen Lin, Michael Petrarca, Shivaani Kummar
Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Anthony W Tolcher, Joshua D Brody, Nishanthan Rajakumaraswamy, Michelle R Kuhne, Torsten Trowe, Anees M Dauki, Shantheri Pai, Ling Han, Kai-Wen Lin, Michael Petrarca, Shivaani Kummar
Phase I Study of GS-3583, a FLT3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Anthony W Tolcher, Joshua D Brody, Nishanthan Rajakumaraswamy, Michelle R Kuhne, Torsten Trowe, Anees M Dauki, Shantheri Pai, Ling Han, Kai-Wen Lin, Michael Petrarca, Shivaani Kummar
Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Anees M Dauki, Nishanthan Rajakumaraswamy, Torsten Trowe, Winnie Weng, Kai-Wen Lin, Emon Elboudwarej, Ann Ran-Ran Qin, Christian Schwabe, Michelle R Kuhne, Ahmed A Othman
Pharmacokinetics, pharmacodynamics, and safety of GS-3583, a FLT3 agonist Fc fusion protein, from single-ascending-dose phase I study in healthy participants. Clinical and translational science 17 (8) (2024)
Anees M Dauki, Nishanthan Rajakumaraswamy, Torsten Trowe, Winnie Weng, Kai-Wen Lin, Emon Elboudwarej, Ann Ran-Ran Qin, Christian Schwabe, Michelle R Kuhne, Ahmed A Othman
Pharmacokinetics, pharmacodynamics, and safety of GS-3583, a FLT3 agonist Fc fusion protein, from single-ascending-dose phase I study in healthy participants. Clinical and translational science 17 (8) (2024)
Anees M Dauki, Chia-Hsiang Hsueh, Ganesh Cherala, Ahmed A Othman
Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug-Drug Interaction Studies? Clinical pharmacology and therapeutics 112 (3) (2022)
Kerry A Rogers, Leslie A Andritsos, Lai Wei, Eric M McLaughlin, Amy S Ruppert, Mirela Anghelina, James S Blachly, Timothy Call, Dai Chihara, Anees M Dauki, Ling Guo, S Percy Ivy, Lacey R James, Daniel Jones, Robert J Kreitman, Gerard Lozanski, David M Lucas, Apollinaire Ngankeu, Mitch Phelps, Farhad Ravandi, Charles A Schiffer, William E Carson, Jeffrey A Jones, Michael R Grever
Phase 2 study of ibrutinib in classic and variant hairy cell leukemia. Blood 137 (25) (2021)